Tag: Arovella
Arovella’s ALA-101 inches toward clinic following key manufacturing achievement
Arovella Therapeutics Ltd, the biotechnology company specialising in iNKT cell therapy, announced that the Good Manufacturing Practice (GMP)-grade lentiviral vector for its lead product, ALA-101, has completed successful manufacturing and quality release testing.
Featured Article
The future of steel engineering: Using CRM systems across supply chains
The construction industry has undergone significant transformation over the past twenty years. Speedpanel, a leading Australian manufacturer of lightweight, fire-rated, and acoustic wall systems, made a groundbreaking entrance in the early '90s, revolutionising the Australian construction landscape.
